Add to Favourites
To login click here

The global clinical trial management system (CTMS) market size is forecast to grow by USD 1,449.16 million between 2022 and 2027, driven by a rise in healthcare expenditure. The increasing prevalence of chronic diseases and rising disposable incomes have increased healthcare expenditure globally. The market is segmented into North America, Europe, Asia, and Rest of World (ROW). The North American region is expected to be the largest market for CTMS, followed by Europe and Asia.